Cook, Anthony et al. published their patent in 2008 |CAS: 142327-44-4

The Article related to oxoadenine preparation tlr7 modulator, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Name: Methyl 2-(3-formylphenyl)acetate

On January 10, 2008, Cook, Anthony; McInally, Tom; Thom, Stephen; Wada, Hiroki published a patent.Name: Methyl 2-(3-formylphenyl)acetate The title of the patent was Preparation of 8-oxoadenine derivatives as modulators of TLR7. And the patent contained the following:

8-Oxoadenine derivatives of formula I [A = aryl, heteroaryl; R1 = H, OH, alkoxy, aryl, cycloalkyl, etc.; Y1-Y3 = bond, alkylene; X1 = bond, O, S, SO2, (substituted) NH; Z1 = alkylene, cycloalkylene; R2 = H, alkyl, cycloalkyl, etc.; R3 = alkyl, hydroxyalkyl, alkoxy, (substituted) amino, etc.; R4 = (substituted) CO2H, SO2NH2, acyl, etc.; n = 0-2] are prepared The 8-oxoadenine derivatives act as modulators of Toll-like Receptor (TLR) 7 and thus may be used in the treatment of asthma, hepatitis, allergic diseases, viral and bacterial infection as well as cancer. Thus, II was prepared, and had pMEC > 7.7 in human TLR7 assay. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Name: Methyl 2-(3-formylphenyl)acetate

The Article related to oxoadenine preparation tlr7 modulator, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Name: Methyl 2-(3-formylphenyl)acetate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Gomez Bouzo, Uxia et al. published their research in Results in Chemistry in 2022 |CAS: 2873-29-2

The Article related to thia muricatacin preparation total synthesis, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Computed Properties of 2873-29-2

On January 31, 2022, Gomez Bouzo, Uxia; Sanchez-Sanz, Irene; Gonzalez, Maria; Gomez, Generosa; Fall, Yagamare published an article.Computed Properties of 2873-29-2 The title of the article was First total synthesis of 7-thia-(-)-muricatacin. And the article contained the following:

A straightforward synthesis of 7-thia-(-)-muricatacin I has been achieved from a com. available starting material and using the furan approach, hence enlarging the scope of methodol. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Computed Properties of 2873-29-2

The Article related to thia muricatacin preparation total synthesis, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Computed Properties of 2873-29-2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Shi, Qian et al. published their patent in 2004 |CAS: 53838-27-0

The Article related to podophyllotoxin derivative preparation anticancer, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Synthetic Route of 53838-27-0

On April 22, 2004, Shi, Qian; Wang, Hui-kang; Oyama, Masayoshi; Vance, John Robert; Chen, Ming S. published a patent.Synthetic Route of 53838-27-0 The title of the patent was Preparation of podophyllotoxin derivatives as anticancer compounds. And the patent contained the following:

Podophyllotoxin derivatives, such as I [R1, R2, R3, R7 = H, alkyl; R4, R6 = alkyl; R5 = H, P(O)(ORa)2; Ra = H, alkyl; T = H; XT = :N; X = bond, O, S, NRb; Rb = H, alkyl; Y = 5-membered heteroaryl or heterocyclyl, optionally substituted with one or more halogen, alkyl, cyclyl, aryl, heteroaryl, heterocyclyl, etc.], were prepared for their therapeutic use as anticancer agents. Thus, podophyllotoxin derivative II was prepared via a multistep synthetic sequence starting from 4′-demethyl-4β-bromo-4-desoxypodophyllotoxin (prepared from podophyllotoxin), 2-aminothiazole-4-acetic acid and (trimethylsilyl)diazomethane. II showed unexpectedly high levels of cellular protein-linked DNA breaks (PLDB) induction in KB cells when tested at 5μg/mL. This invention also features a method for treating cancer. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Synthetic Route of 53838-27-0

The Article related to podophyllotoxin derivative preparation anticancer, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Synthetic Route of 53838-27-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Huang, Shuangping et al. published their research in Synthetic Communications in 2015 |CAS: 3976-69-0

The Article related to tarchonanthuslactone synthesis diastereoselective mukaiyama aldol, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: 3976-69-0

Huang, Shuangping; Liu, Dongwang; Tang, Linjun; Huang, Fei Fei; Zhang, Jianting; Wang, Xiaoji published an article in 2015, the title of the article was Total Synthesis of (+)-7-Epi-tarchonanthuslactone via a Chelation-Controlled Mukaiyama Aldol Reaction.Recommanded Product: 3976-69-0 And the article contains the following content:

An asym. total synthesis of (+)-7-epi-tarchonanthuslactone (I) was achieved from com. available Me (R)-3-hydroxybutyrate. The key step employed a diastereoselective chelation-controlled Mukaiyama aldol reaction to construct the chiral hydroxyl group at the C-5 position. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Recommanded Product: 3976-69-0

The Article related to tarchonanthuslactone synthesis diastereoselective mukaiyama aldol, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

He, Tian-Jun et al. published their research in European Journal of Organic Chemistry in 2015 |CAS: 3976-69-0

The Article related to melanoxadin melanoxazal fungus metabolite preparation configuration, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Computed Properties of 3976-69-0

He, Tian-Jun; Zhu, Shijun; Lu, Xiao-Wei; Wu, Yikang; Li, Yan published an article in 2015, the title of the article was Absolute Configurations of Melanoxadin, MR-93A, Melanoxazal, and MR-93B.Computed Properties of 3976-69-0 And the article contains the following content:

Fungal metabolites melanoxadin, MR-93A, melanoxazal and MR-93B were synthesized with the key stereogenic centers derived from com. available chiral building blocks. The optically active synthetic products with well-defined absolute configurations provided authentic samples for the stereoisomers of these oxazole-containing natural products and thus allowed for unambiguous assignments of their relative and absolute configurations. The large discrepancies in the optical rotations between the natural and the pure synthetic samples are discussed. Some errors in the previously reported NMR signal assignments are also corrected The synthesis of the target compounds was achieved using (2S)-2-hydroxypropanoic acid Et ester and (3S)-3-hydroxybutanoic acid, (3R)-3-hydroxybutanoic acid as chiral source materials. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Computed Properties of 3976-69-0

The Article related to melanoxadin melanoxazal fungus metabolite preparation configuration, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Computed Properties of 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Huang, Shuangping et al. published their research in Synlett in 2015 |CAS: 3976-69-0

The Article related to tarchonanthuslactone synthesis mukaiyama aldol yamaguchi lactonization, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: 3976-69-0

On September 30, 2015, Huang, Shuangping; Liu, Dongwang; Tang, Linjun; Huang, Feifei; Yang, Wei; Wang, Xiaoji published an article.Recommanded Product: 3976-69-0 The title of the article was A Concise and Versatile Total Synthesis of All Stereoisomers of Tarchonanthuslactone. And the article contained the following:

We describe the versatile and concise total synthesis of all stereoisomers of tarchonanthuslactone from (R)- or (S)-3-hydroxybutyrate via eight steps. The key steps of the synthesis include a highly diastereoselective chelation-controlled Mukaiyama aldol reaction of a p-methoxybenzyl-protected aldehyde and a Yamaguchi lactonization of a δ-hydroxy-trans-α,β-unsaturated carboxylic acid. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Recommanded Product: 3976-69-0

The Article related to tarchonanthuslactone synthesis mukaiyama aldol yamaguchi lactonization, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

McInally, Thomas et al. published their patent in 2007 |CAS: 142327-44-4

The Article related to purine derivative preparation immunomodulator toll like receptor activity, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Product Details of 142327-44-4

On March 22, 2007, McInally, Thomas; Thom, Stephen; Wada, Hiroki published a patent.Product Details of 142327-44-4 The title of the patent was Purine derivatives having immunomodulating properties. And the patent contained the following:

Purine derivatives, such as I [R = amino group, such as NMe2 or NHMe, or a N-bound nitrogen containing heterocycle, such as 1-pyrrolidinyl or 4-methyl-1-piperazinyl; X = alkylene linking group, such as (CH2)m, m = 3, 4; X1 = alkylene linking group, such as (CH2)n, n = 2, 3], were prepared for use in immunomodulating pharmaceutical compositions which are useful in the treatment of diseases or conditions in which modulation of TLR7 activity is beneficial. These diseases or conditions may include allergic or viral diseases, cancers, asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis. Thus, purine derivative I [R = NMe2, X = X1 = (CH2)3] was prepared in 10 steps starting from 2,6-dichloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine, BuONa, Br(CH2)3Br, H2N(CH2)3OH, and BrCH2-3-C6H4CH2CO2Me. The prepared purine derivatives were tested for interferon inducing activity in rat spleen cells and for activation of recombinant human TLR7. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Product Details of 142327-44-4

The Article related to purine derivative preparation immunomodulator toll like receptor activity, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Product Details of 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Abbott, Philip et al. published their patent in 2007 |CAS: 142327-44-4

The Article related to purine derivative preparation immunomodulator toll like receptor activity, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Electric Literature of 142327-44-4

On March 29, 2007, Abbott, Philip; Bonnert, Roger Victor; Brough, Stephen; Chohan, Kamaldeep; McInally, Thomas; Thom, Stephen; Isobe, Yoshiaki; Nakamura, Kei; Tojo, Shingo published a patent.Electric Literature of 142327-44-4 The title of the patent was Purine derivatives for the treatment of viral or allergic diseases and cancers. And the patent contained the following:

Purine derivatives, such as I [R = N-bound nitrogen containing heterocycle, such as 3-pyrrolidinyl, 3-azetidinyl or 1-methyl-4-piperidinyl; R3 = CH2CO2Me, R4 = H, or R3 = H, R4 = CH2CO2Me; X = alkylene linking group, such as (CH)n, n = 3, 4], were prepared for use in immunomodulating pharmaceutical compositions which are useful in the treatment of diseases or conditions in which modulation of TLR7 activity is beneficial. These diseases or conditions may include allergic or viral diseases, cancers, asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis. Thus, purine derivative I [R = 4-piperidinyl, R3 = CH2CO2Me, R4 = H; X = (CH2)3] was prepared in 8 steps starting from 2,6-dichloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine, BuONa, Br(CH2)3NHCO2CMe3, 4-oxo-1-piperidinecarboxylic acid tert-Bu ester, and OHC-3-C6H4CH2CO2Me. The prepared purine derivatives were tested for interferon inducing activity in rat spleen cells and for activation of recombinant human TLR7. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Electric Literature of 142327-44-4

The Article related to purine derivative preparation immunomodulator toll like receptor activity, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Electric Literature of 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Veena, Bacchu et al. published their research in Synlett in 2014 |CAS: 3976-69-0

The Article related to macrosphelide preparation total synthesis cytotoxic anticancer antitumor agent, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: (R)-Methyl 3-hydroxybutanoate

Veena, Bacchu; Sharma, Gangavaram V. M. published an article in 2014, the title of the article was Stereoselective synthesis of macrosphelide I.Recommanded Product: (R)-Methyl 3-hydroxybutanoate And the article contains the following content:

An efficient total synthesis of (4R,7E,9R,10S,15R,16S)-9,15-dihydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadec-7-ene-2,6,12-trione (macrosphelide I) has been achieved starting from com. available chiral materials, Et (S)-lactate and Me (R)-3-hydroxybutyrate. The synthesis of the target compound was carried out by a titanium(IV) promoted regioselective nucleophilic opening reaction of epoxy alc. with benzoic acid, Sharpless epoxidation, ring-closing metathesis and Yamaguchi esterification as key steps for the construction of the 16-membered macrotriolide. (2E,4S)-4-[(4-Methoxyphenyl)methoxy]-2-penten-1-ol was used as a starting material. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Recommanded Product: (R)-Methyl 3-hydroxybutanoate

The Article related to macrosphelide preparation total synthesis cytotoxic anticancer antitumor agent, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Recommanded Product: (R)-Methyl 3-hydroxybutanoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Atamanyuk, Dmytro et al. published their patent in 2012 |CAS: 227940-70-7

The Article related to purine dimer derivative preparation antibacterial antivirulence agent immunomodulator, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Category: esters-buliding-blocks

On December 20, 2012, Atamanyuk, Dmytro; Denis, Alexis; Gerusz, Vincent; Ledoussal, Benoit; Bonvin, Yannick; Desroy, Nicolas; Gold, Johan; Moreau, Francois; Oxoby, Mayalen published a patent.Category: esters-buliding-blocks The title of the patent was Preparation of purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections. And the patent contained the following:

The invention relates to the compounds I [wherein A is Ph, naphthyl and 5-10 membered monocyclic or bicyclic unsaturated heterocycle, optionally substituted by a group R1 which is as defined in the application and is itself optionally substitutes by a group R2 which is as defined in the application and is itself optionally substituted by a group R3 which is defined in the application, Y and W, identical or different, are H, (C1-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, Ph or 4-10 monocyclic or bicyclic saturated or unsaturated heterocycle, optionally substituted by R1, or Y and/or W form a 4-10 membered cycle with R1, or Y and W form with N a saturated or unsaturated nitrogenous 4-10 membered mono, bi or tricyclic system, fused, bridged or spiro system, said system being optionally substituted by R1, said system being different from morpholine, with the proviso that when Y and A are Ph or heterocycle, W is not H] and their addition salts thereof with acids and bases. The invention also relates to a process and intermediates for their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity, and pharmaceutical compositions and associations containing them. Thus, 6-[4-(methanesulfonyl)phenyl]purine II was prepared from 2,6-dichloro-9H-purine vis tetrahydropyranylation with 3,4-dihydro-2H-pyran in EtOAc containing catalytic PTSA; Suzuki coupling reaction with [4-(MeSO2)C6H4]B(OH)2 in aqueous DME containing K2CO3 and catalytic Pd(PPh3)4; amination with tert-Bu [(piperidin-4-yl)methyl]carbamate in MeCN containing DIPEA; and N-deprotection with HCl in THF/dioxane. The antibacterial activity of II was determined [IC50 = <300 μM vs. dltA gene of S. aureus]. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Category: esters-buliding-blocks

The Article related to purine dimer derivative preparation antibacterial antivirulence agent immunomodulator, Biomolecules and Their Synthetic Analogs: Others, Including Purines, Pyrimidine Nucleic Acid Bases, Flavins, Lignans and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics